Biosimilars: new insights into the regulatory approval process in Europe

April 10, 2018, by Johanna Mielke & Byron Jones

ESR Johanna’s latest publication gives insights into the clinical development strategies used to obtain approval for proposed biosimilars and how these have been assessed by the European Medicines Agency.

ESR Nico takes part in the “Leader of Tomorrow” challenge for DIA Europe 2018

March 1, 2018, by Pamela Forster & Nico Ballerini

DIA has designed new elements for DIA Europe 2018 to specifically provide skill development and career support to students and young professionals. Registered young professionals and students will be benefit from the entire DIA Europe 2018 programme, in addition to specialty sessions specifically tailored to address their professional goals.

Young Statisticians Seminar (25th October 2017), Vienna

October 19, 2017, by Johanna Mielke, Julia Niewczas & Nicolas Ballarini

This year, three IDEAS ESRs had the responsibility of organising the annual International Biometric Society Herbstseminar in Vienna.

Statistical Methods and Designs in Clinical Oncology Symposium (9th November 2017), Paris

, by Pamela Forster

This Symposium is open to statisticians interested in advanced methods for clinical research in oncology.

IDEAS Summer School II (11th-15th September 2017)

September 17, 2017, by Pamela Forster

The second IDEAS Summer School took place at the Politecnico di Torino in Italy

IDEAS demonstrates medical statistics to local community

May 26, 2017, by Pamela Forster

Discover more about IDEAS’ involvement in Lancaster University’s Community Day.

The role of a statistician in drug development: Phase III

March 5, 2017, by Enya, Johanna and Julia

PSI Careers fairs and an introduction to IDEAS and Statistical Methods

March 1, 2017, by Tom Harrison

PSI Careers Event at the University of Reading and the IDEAS journey

Pavel Mozgunov is awarded the Nick Smith Prize

February 24, 2017, by Allan Gordon

The Nick Smith Prize is awarded to the Statistics PhD students during their 18 month appraisal on the basis of their excellence in research.

The role of a statistician in drug development: Phase II

February 20, 2017, by Marius, Nico and Saswati